Nanoliposomes protect against AL amyloid light chain protein-induced endothelial injury

Seth Truran, Volkmar Weissig, Marina Ramirez-Alvarado, Daniel A. Franco, Camelia Burciu, Joseph Georges, Shishir Murarka, Winter A. Okoth, Sara Schwab, Parameswaran Hari, Raymond Q. Migrino

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


Context: A newly-recognized pathogenic mechanism underlying light chain amyloidosis (AL) involves endothelial dysfunction and cell injury caused by misfolded light chain proteins (LC). Nanoliposomes (NL) are artificial phospholipid vesicles that could attach to misfolded proteins and reduce tissue injury. Objective: To test whether co-treatment with NL reduces LC-induced endothelial dysfunction and cell death. Methods: Abdominal subcutaneous adipose arterioles from 14 non-AL subjects were cannulated; dilator response to acetylcholine and papaverine were measured at baseline and following 1-hour exposure to LC (20 μg/mL, 2 purified from AL subjects' urine, 1 from human recombinant LC [AL-09]) ± NL (phosphatidylcholine/cholesterol/ phosphatidic acid 70/25/5 molar ratio) or NL alone. Human aortic artery endothelial cells (HAEC) were exposed to Oregon Green-labeled LC ± NL for 24 hours and intracellular LC and apoptosis (Hoechst stain) were measured. Circular dichroism spectroscopy was performed on AL-09 LC ± NL to follow changes in secondary structure and protein thermal stability. Results: LC caused impaired dilation to acetylcholine that was restored by NL (control-94.0 ± 1.8%, LC-65.0 ± 7.1%, LC + NL-95.3 ± 1.8%, p ≤ 0.001 LC versus control or LC + NL). NL protection was inhibited by L-NG-nitroarginine methyl ester. NL increased the beta sheet structure of LC, reduced endothelial cell internalization of LC and protected against LC-induced endothelial cell death. Conclusions: LC induced human adipose arteriole endothelial dysfunction and endothelial cell death, which were reversed by co-treatment with NL. This protection may partly be due to enhancing LC protein structure and reducing LC internalization. Nanoliposomes represent a promising new class of agents to ameliorate tissue injury from protein misfolding diseases such as AL.

Original languageEnglish (US)
Pages (from-to)69-73
Number of pages5
JournalJournal of Liposome Research
Issue number1
StatePublished - Mar 2014


  • Amyloid
  • Endothelial function
  • Heart failure
  • Lipid nanoparticles
  • Nanoliposomes

ASJC Scopus subject areas

  • Pharmaceutical Science


Dive into the research topics of 'Nanoliposomes protect against AL amyloid light chain protein-induced endothelial injury'. Together they form a unique fingerprint.

Cite this